1st Quarter - Report

SLC HEALTH STRATEGIES, LLC for EISAI INC.

Firm
Client
Income
$54,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

S. Con. Res 8 -- Concurrent Resolution on the Budget For Fiscal Year 2014 H Con Res 25 -- Establishing the budget for the US Government for FY 2014 and setting forth appropriate budgetary levels for FY 15 through 2033 HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs Medicare coverage for obesity medications

LobbyistCovered position, as disclosed
SHARON COHEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.Con.Res. 25 (113th), H.R. 933 (113th), S.Con.Res. 8 (113th)

Financial Institutions/Investments/Securities FIN

Student Loan Auction Rate Securities (SLARS) legislation

LobbyistCovered position, as disclosed
SHARON COHEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Implementation of the new health care reform law - PL 111-148, specifically with regard to those provisions impacting Medicare/Medicaid prescription drug coverage in the essential benefit pkg, and other matters

LobbyistCovered position, as disclosed
SHARON COHEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Education EDU

Student Loan Auction Rate Securities (SLARS) legislation

LobbyistCovered position, as disclosed
SHARON COHEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

obesity product matters as well as FDA funding and DEA scheduling of controlled substances; no specific bills yet introduced

LobbyistCovered position, as disclosed
SHARON COHEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.